Johnson & Johnson’s Commitment to Expand Efforts to Fight Intestinal Worms in Children Could Protect up to 100 million Young People

September 9, 2010 by Kim Koporc

9/9/10 - Johnson & Johnson to quadruple mebendazole donations over five years.

PRESS RELEASE

Johnson & Johnson’s announcement that it will quadruple mebendazole donations over five years to combat intestinal worms in children is remarkable. The infusion of 200 million new doses to treat children twice a year has the power to improve the health of more than 100 million children suffering from soil-transmitted helminthiasis (STH)—and it has the potential to transform the lives of an entire generation.

STH is endemic to some of the poorest tropical and sub-tropical regions of the world—where sanitation and clean water are scarce. Up to 800 million children are affected by this disease, increasing their vulnerability to malnutrition and other serious infections. STH is preventable and treatable through a comprehensive approach of deworming medication and access to clean water, sanitation, and hygiene education.

“This donation paves the way for CWW to reach more children, who desperately need life-saving drugs and their basic needs met,” said Mark Rosenberg, director of The Task Force for Global Health. “Johnson & Johnson is providing a model for how business, governments, and in-country health providers can unite to address our most serious health issues and improve quality of life for millions of children globally.”

To date, Children Without Worms (CWW), a partnership between the The Task Force for Global Health and Johnson & Johnson has worked to treat more than 20 million children per year with mebendazole, and to address the root causes of STH in eight countries: Bangladesh, Cambodia, Cameroon, Cape Verde, Lao PDR, Nicaragua, Uganda and Zambia. In 2001, the World Health Assembly set as a goal to treat at least 75 percent of all school age children at risk of STH by 2010. This partnership and the Company’s contributions of mebendazole are credited as primary drivers leading Cambodia, Cape Verde, Loa PDR, Nicaragua, and Uganda to reach the WHA target years ahead of the target date.

CONTACT: Kim Koporc, Director of Children Without Worms
kkoporc@taskforce.org

Comment by Anne Beam, MD

January 5, 2011 at 11:51 PM

Dear Kim Koporc,
Please contact me as I am going to Burundi in Feb 2011. I am a family physician and will be going with a mission group. We would like to better understand the needs of the children. Also, we would like to discuss participation in any ongoing programs that you might have. Perhaps, just to visit or to assist. Thank you! Anne Beam

Comment by Mark Muranda Luvisia

April 25, 2011 at 12:56 PM

Dear Kim Koporc
I am the Coordinator School of Health Sciences at Eldoret Campus of Mount Kenya University,a pioneering private chartered private University in the region to offer courses in Health Sciences.Between 23rd-24th March 2011 i conducted a survey on intestinal helminths and intestinal amoebiasis at Langas Primary school in Eldoret,Kenya.This was done in collaboration with Kenya Medical Research Institute(KEMRI) which is located about 250Kms away from the school.
Preliminary results shows that over 45 percnt of the 250 samples had cysts,eggs and other larval forms of Trichiuris trichiura,Roundworms, Hookworms,I.nana, I.iodoamoeba, E.coli and E.histolytica.Kindly,donate drugs for the infected because it's unethical to disclose the findings without treatment.The target population is 1500 children.May God bless the work of your hands.

Comment by Maria

October 18, 2011 at 03:06 PM

Hello, i wanted more information about your fundings to non-profit orginizations , please email me when ever , Thank you !